Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-30
DOI
10.1038/s41375-020-0880-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NFκB signaling
- (2019) Daniel A. C. Fisher et al. LEUKEMIA
- IL-1 Family Cytokine Regulation of Vascular Permeability and Angiogenesis
- (2019) Erin Fahey et al. Frontiers in Immunology
- Primary myelofibrosis marrow-derived CD14+/CD34- monocytes induce myelofibrosis-like phenotype in immunodeficient mice and give rise to megakaryocytes
- (2019) Taghi Manshouri et al. PLoS One
- IL-6, IL-17 and Stat3 are required for auto-inflammatory syndrome development in mouse
- (2018) Takatsugu Oike et al. Scientific Reports
- Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis
- (2017) T Maekawa et al. LEUKEMIA
- Generation of a transgenic mouse line for conditional expression of human IL-6
- (2016) Taiki Mori et al. EXPERIMENTAL ANIMALS
- Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies
- (2016) A. A. Zahr et al. HAEMATOLOGICA
- Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosis
- (2016) Srdan Verstovsek et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations
- (2016) M Marchetti et al. LEUKEMIA
- Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies
- (2016) A. A. Zahr et al. HAEMATOLOGICA
- Interleukin-6 Stimulates Defective Angiogenesis
- (2015) G. Gopinathan et al. CANCER RESEARCH
- Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients
- (2014) H. L. Geyer et al. BLOOD
- Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis
- (2014) R. Rampal et al. BLOOD
- Loss of TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease accelerator
- (2014) T. Kameda et al. BLOOD
- An Interleukin-1 Beta-Encoding Retrovirus Exhibits Enhanced ReplicationIn Vivo
- (2014) Edward P. Browne JOURNAL OF VIROLOGY
- Fibrocytes develop outside the kidney but contribute to renal fibrosis in a mouse model
- (2013) Barbara Reich et al. KIDNEY INTERNATIONAL
- A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
- (2012) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
- (2012) Claire Harrison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of Markers that Distinguish Monocyte-Derived Fibrocytes from Monocytes, Macrophages, and Fibroblasts
- (2009) Darrell Pilling et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now